All PlansCoverageHigh impact
Hematopoietic Cell Transplantation for Solid Tumors of Childhood
Blue Cross & Blue Shield of Mississippi·MS · Oncology, Hematology, Pediatrics·Medical Policy
We identified it
Jun 20, 2026
Summary
Blue Cross Blue Shield of Mississippi has updated their medical policy A.8.01.34 for Hematopoietic Cell Transplantation (bone marrow/stem cell transplants) for childhood solid tumors including neuroblastoma, Ewing sarcoma, rhabdomyosarcoma, and Wilms tumor. This policy defines coverage criteria and risk stratification for these high-cost transplant procedures in pediatric oncology patients.
Action Required
Immediately: Billing team must review updated BCBS Mississippi policy A.8.01.34 for pediatric hematopoietic cell transplantation coverage criteria. Ensure prior authorization requests include proper risk stratification documentation (low, intermediate, high-risk) and tumor staging per International Neuroblastoma Staging System or other specified staging systems. Verify patient eligibility against updated coverage criteria before scheduling transplant procedures to prevent claim denials.